DK3203835T3 - Fremgangsmåde til hypotermisk lagring af placentavæv - Google Patents

Fremgangsmåde til hypotermisk lagring af placentavæv Download PDF

Info

Publication number
DK3203835T3
DK3203835T3 DK15849362.7T DK15849362T DK3203835T3 DK 3203835 T3 DK3203835 T3 DK 3203835T3 DK 15849362 T DK15849362 T DK 15849362T DK 3203835 T3 DK3203835 T3 DK 3203835T3
Authority
DK
Denmark
Prior art keywords
placent
tissue
procedure
hypothermic storage
hypothermic
Prior art date
Application number
DK15849362.7T
Other languages
English (en)
Inventor
Jeremy B Vines
Howard P Walthall Jr
Katie C Mowry
Original Assignee
Prime Merger Sub Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prime Merger Sub Llc filed Critical Prime Merger Sub Llc
Application granted granted Critical
Publication of DK3203835T3 publication Critical patent/DK3203835T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0236—Mechanical aspects
    • A01N1/0242—Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0236—Mechanical aspects
    • A01N1/0263—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving, e.g. cool boxes, blood bags or "straws" for cryopreservation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Mechanical Engineering (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Thermal Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
DK15849362.7T 2014-10-07 2015-10-07 Fremgangsmåde til hypotermisk lagring af placentavæv DK3203835T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/508,398 US20160095307A1 (en) 2014-10-07 2014-10-07 Method and composition for hypothermic storage of placental tissue
PCT/US2015/054494 WO2016057669A1 (en) 2014-10-07 2015-10-07 Method and composition for hypothermic storage of placental tissue

Publications (1)

Publication Number Publication Date
DK3203835T3 true DK3203835T3 (da) 2022-05-09

Family

ID=55631795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15849362.7T DK3203835T3 (da) 2014-10-07 2015-10-07 Fremgangsmåde til hypotermisk lagring af placentavæv

Country Status (8)

Country Link
US (5) US20160095307A1 (da)
EP (2) EP3203835B1 (da)
JP (1) JP6595588B2 (da)
AU (1) AU2015328092B2 (da)
DK (1) DK3203835T3 (da)
ES (1) ES2913155T3 (da)
PT (1) PT3203835T (da)
WO (1) WO2016057669A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
CN107296041B (zh) * 2017-07-02 2020-12-25 江西瑞济生物工程技术股份有限公司 一种新鲜羊膜保存液及新鲜羊膜保存方法与应用
CN108684653A (zh) * 2018-03-23 2018-10-23 杭州联泽生物科技有限公司 一种胎盘保存液及其制备方法
CN109362709A (zh) * 2018-11-21 2019-02-22 江苏赛尔时代健康产业有限公司 一种胎盘组织保存液及其制备方法
JP7336784B2 (ja) * 2019-05-15 2023-09-01 国立大学法人富山大学 創傷接触部材
WO2021071430A1 (en) * 2019-10-08 2021-04-15 Cellresearch Corporation Pte. Ltd. A mesenchymal stem cell storing or transport formulation and methods of making and using the same

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
US6492103B1 (en) * 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
JP2004528021A (ja) * 2001-02-14 2004-09-16 アンスロジェネシス コーポレーション 分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞
WO2004000164A2 (en) * 2002-06-24 2003-12-31 Amniotech, Inc. Amniotic membrane mediated delivery of bioactive molecules
US20070010008A1 (en) * 2005-06-29 2007-01-11 Tissuetech, Inc. Ex vivo expansion of primary animal cells
US20050196460A1 (en) * 2004-03-08 2005-09-08 Malinin Theodore I. Particulate cartilage compositions, processes for their preparation and methods for regenerating cartilage
GB0514567D0 (en) * 2005-07-15 2005-08-24 Univ Nottingham Surgical membrane
US8871198B2 (en) * 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
WO2008060377A2 (en) * 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
KR20160093739A (ko) * 2006-10-06 2016-08-08 안트로제네시스 코포레이션 천연(텔로펩티드) 태반 콜라겐 조성물
RS52921B (en) * 2007-02-12 2014-02-28 Anthrogenesis Corporation TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL CELL CELLS
US7960098B2 (en) * 2007-07-12 2011-06-14 Warsaw Orthoperic, Inc. Methods and compositions for the preservation of cells and tissues
WO2009120996A1 (en) * 2008-03-27 2009-10-01 Biolife Solutions, Inc. Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue
EP3345998A1 (en) * 2010-02-18 2018-07-11 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products
JP5796290B2 (ja) * 2010-12-03 2015-10-21 公益財団法人先端医療振興財団 膵島組織保存溶液及びそれを用いる方法
US20120207717A1 (en) * 2011-02-14 2012-08-16 Sing George L Methods for treating inhalation injury
AU2012250794B2 (en) * 2011-05-03 2015-11-05 Immunovative Therapies, Ltd. Methods for handling biological drugs containing living cells
US20130136773A1 (en) * 2011-09-30 2013-05-30 NuTech Spine, Inc. Expandable Placental Membrane and Methods of Making and Storing Same
US8932805B1 (en) * 2011-10-31 2015-01-13 BioDlogics, LLC Birth tissue material and method of preparation
CN104703572B (zh) * 2012-03-01 2017-07-04 安尼奥楚公司 用于获得干细胞的组织回收、存储以及外植体培养装置
US9560846B2 (en) * 2012-08-10 2017-02-07 Paragonix Technologies, Inc. System for hypothermic transport of biological samples
FR2996413B1 (fr) * 2012-10-10 2014-12-05 Maco Pharma Sa Procede pour conserver le sang placentaire
US20140212390A1 (en) * 2013-01-30 2014-07-31 NuTech Medical, Inc. Placental Membrane Preparation and Methods of Making and Using Same
US20150007919A1 (en) * 2013-01-31 2015-01-08 Wu Xi Jidaer Wheel Co., Ltd. Hinged type locking ring quick locking device
US9427273B2 (en) * 2013-02-20 2016-08-30 BioDlogics, LLC Biologic balloon and method of use
CN103789262A (zh) * 2014-02-17 2014-05-14 宁波普莱森特生物科技有限公司 一种临床应用级胎盘造血干细胞的制备方法及保存方法
CA2948133A1 (en) * 2014-05-07 2015-11-12 Osiris Therapeutics, Inc. Immunocompatible amniotic membrane products
SG11201609253PA (en) * 2014-05-07 2016-12-29 Osiris Therapeutics Inc Immunocompatible chorionic membrane products
TW201603818A (zh) * 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法

Also Published As

Publication number Publication date
AU2015328092A1 (en) 2017-04-27
US20230077597A1 (en) 2023-03-16
WO2016057669A1 (en) 2016-04-14
EP4035530A1 (en) 2022-08-03
ES2913155T3 (es) 2022-05-31
PT3203835T (pt) 2022-05-11
EP3203835A4 (en) 2018-03-07
EP3203835A1 (en) 2017-08-16
EP3203835B1 (en) 2022-04-06
US20160095307A1 (en) 2016-04-07
JP2017531653A (ja) 2017-10-26
JP6595588B2 (ja) 2019-10-23
US20160100571A1 (en) 2016-04-14
AU2015328092B2 (en) 2018-11-01
US20160192639A1 (en) 2016-07-07
US20160101135A1 (en) 2016-04-14

Similar Documents

Publication Publication Date Title
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3371171T3 (da) Inhibitorer af RET
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3851537T3 (da) Behandling af hyperbilirubinæmi
DK3116533T3 (da) Deletion af dystrophingenexon under anvendelse af genmanipulerede nukleaser
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK3492632T3 (da) Metoder til behandling af lithiumholdige materialer
DK3166976T3 (da) Anti-pd-l1-kombinationer til behandling af tumorer
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3164380T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3157534T3 (da) Acetylcholinesterasehæmmere til behandling af dermatologiske tilstande
DK3233813T3 (da) Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3186242T3 (da) Alfa-amino-beta-carboxymuconsyre-semialdehyd-decarboxylasehæmmere
DK3114120T3 (da) Tetrazolon-substituerede dihydropyridinon-mgat2-hæmmere
DK3203835T3 (da) Fremgangsmåde til hypotermisk lagring af placentavæv
DK3164394T3 (da) Gls1-inhibitorer til behandling af sygdomme
DK3166611T3 (da) Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxypicolinsyrer
DK3132009T3 (da) Fremgangsmåde
DK3185867T3 (da) Krystalliseringsfremgangsmåde af aripiprazolderivater i forlængede frigivelsesformuleringer til behandling af skizofreni
DK3204352T3 (da) Hæmmere af lysin-gingipain
DK2921050T3 (da) Fremgangsmåde til udbringning af plantebeskyttelsesmidler